Lonza sharpens pharma focus with CHF4.2B sale of Specialty Ingredients to Bain Capital and Cinven

Related Articles

FormattedPicture

FOOD INGREDIENTS NEWS

After EU regulators deemed the European Commission decision to ban titanium dioxide a “manifest error” of assessment, the status of TiO2 is being questioned... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Bioavailability equals convenience – the more easily a nutrient can be absorbed, the easier consumers can fit those products into their busy lifestyles while still... Read More

FormattedPicture

BUSINESS NEWS

New nutraceutical trends are emerging from the COVID-19 pandemic, as consumer interest spikes in gut health, joint health and mobility, active nutrition and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Mobility is quality of life. As consumers age, their interest in products and foods that facilitate healthy aging grows. However, younger generations are more informed... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Creating clean-label ingredients for nutrition and nutraceutical products and introducing new or rethinking traditional formats for those products were key themes at the... Read More

trans